REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 83 filers reported holding REPROS THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $970,000 | -19.9% | 1,001,000 | 0.0% | 0.21% | -8.9% |
| Q4 2015 | $1,211,000 | -85.6% | 1,001,000 | -11.6% | 0.24% | -88.7% |
| Q3 2015 | $8,413,000 | +3.9% | 1,132,367 | 0.0% | 2.08% | +11.5% |
| Q2 2015 | $8,096,000 | -16.8% | 1,132,367 | 0.0% | 1.86% | -9.2% |
| Q1 2015 | $9,727,000 | -13.8% | 1,132,367 | 0.0% | 2.05% | -48.6% |
| Q4 2014 | $11,290,000 | +0.7% | 1,132,367 | 0.0% | 4.00% | -7.7% |
| Q3 2014 | $11,210,000 | -35.4% | 1,132,367 | +12.9% | 4.33% | -26.7% |
| Q2 2014 | $17,358,000 | +74.5% | 1,003,367 | +79.0% | 5.90% | +72.4% |
| Q1 2014 | $9,945,000 | +18.3% | 560,600 | +22.0% | 3.42% | +8.7% |
| Q4 2013 | $8,409,000 | – | 459,508 | – | 3.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,001,000 | $970,000 | 0.21% |
| Allegis Investment Advisors, LLC | 341,669 | $331,000 | 0.19% |
| GENERAL AMERICAN INVESTORS CO INC | 396,123 | $384,000 | 0.04% |
| Alambic Investment Management, L.P. | 114,591 | $111,000 | 0.04% |
| Gruss Capital Management LP | 600,000 | $582,000 | 0.02% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 102,086 | $99,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 323,429 | $314,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 27,931 | $27,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $3,000 | 0.00% |
| Airain ltd | 13,690 | $13,000 | 0.00% |